Evidence-based recommendations in idiopathic pulmonary fibrosis: a year is a long time in interstitial lung disease
Am J Respir Crit Care Med
.
2012 Jul 1;186(1):5-7.
doi: 10.1164/rccm.201205-0883ED.
Authors
Joachim Müller-Quernheim
,
Athol Wells
PMID:
22753682
DOI:
10.1164/rccm.201205-0883ED
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anticoagulants / therapeutic use*
Female
Humans
Idiopathic Pulmonary Fibrosis / drug therapy*
Male
Warfarin / therapeutic use*
Substances
Anticoagulants
Warfarin